Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study

被引：0
|
作者：
Sofia Jönsson
Bob Olsson
Jenny Söderberg
Hans Wadenvik
机构：
[1] Sahlgrenska University Hospital,Section of Hematology, Department of Internal Medicine
[2] Sahlgrenska University Hospital,Department of Neurochemistry and Psychiatry
[3] Health Solutions AB,undefined
来源：
Annals of Hematology | 2017年 / 96卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1419 / 1419
相关论文
共 50 条
  • [1] Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
    Sofia Jönsson
    Bob Olsson
    Jenny Söderberg
    Hans Wadenvik
    Annals of Hematology, 2012, 91 : 679 - 685
  • [2] Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study
    Jonsson, Sofia
    Olsson, Bob
    Soderberg, Jenny
    Wadenvik, Hans
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 679 - 685
  • [3] Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study (vol 91, pg 679, 2017)
    Jonsson, Sofia
    Olsson, Bob
    Soderberg, Jenny
    Wadenvik, Hans
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1419 - 1419
  • [4] Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study
    Alsobhi, Enaam
    Abrar, Mohammed Burhan
    Abdelaal, Mohammed
    Alsaeed, Ahmed
    Absi, Ahmed
    Alzahrani, Zayed
    El-Hennaidi, Lhab
    Alshehri, Mohammed Ali
    Warsi, Ashraf
    Bayashoot, Safaa
    Hashem, Heba
    Merdad, Anas
    Radi, Suhaib
    Shiekhi, Hanadi
    Al-Amri, Abdulfattah
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 882 - 886
  • [5] Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study
    Francis, Jose
    Palaniappan, Muthiah
    Dubashi, Biswajit
    Pradhan, Suresh Chandra
    Chandrasekaran, Adithan
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (01) : 30 - 33
  • [6] Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study
    Matti, Bassam Francis
    Naji, Alaadin Sahham
    Alwan, Alaa Fadhil
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (04) : 387 - 393
  • [7] Adherence to Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: A Brazilian Single-Center Cohort
    de Almeida, Maria H.
    Pagnano, Katia B. B.
    Vigorito, Afonso C.
    Lorand-Metze, Irene
    de Souza, Carmino A.
    ACTA HAEMATOLOGICA, 2013, 130 (01) : 16 - 22
  • [8] PREGNANCY AMONG THE PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY
    Chelysheva, E. Y.
    Turkina, A. G.
    Gusarova, G. A.
    Kolosheinova, T. I.
    Sokolova, M. A.
    Khoroshko, N. D.
    Pepelyaeva, V. M.
    Gavrilova, L. V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 262 - 262
  • [9] Hematologic, cytogenetic, and molecular responses to imatinib therapy for chronic myeloid leukemia: a single-center experience in Turkey
    Bilen, Yusuf
    Erdem, Fuat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (01) : 31 - 38
  • [10] STUDY ON ADHERENCE TO IMATINIB THERAPY AMONG CHILDREN WITH CHRONIC MYELOID LEUKAEMIA
    Boddu, Deepthi
    Thankamony, Priyakumari
    Guruprasad, S.
    Nair, Manjusha
    Rajeswari, Binitha
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S176 - S176
12345